The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126051981 12605198 1 I 2014 20160718 20160729 20160729 PER US-ASTRAZENECA-2016SE79005 ASTRAZENECA 65.00 YR M Y 113.40000 KG 20160729 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126051981 12605198 1 PS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 21153 40 MG CAPSULE QD
126051981 12605198 2 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 21153 40 MG CAPSULE QD
126051981 12605198 3 SS NEXIUM 24HR ESOMEPRAZOLE MAGNESIUM 1 Oral DAILY U 0
126051981 12605198 4 SS NEXIUM 24HR ESOMEPRAZOLE MAGNESIUM 1 Oral DAILY U 0
126051981 12605198 5 SS OMEPRAZOLE. OMEPRAZOLE 1 Oral U 0 40 MG QD
126051981 12605198 6 SS OMEPRAZOLE. OMEPRAZOLE 1 Oral U 0 40 MG QD
126051981 12605198 7 C XARELTO RIVAROXABAN 1 Oral 0 20 MG QD
126051981 12605198 8 C AZOR AMLODIPINE BESYLATEOLMESARTAN MEDOXOMIL 1 Oral 0 540 MG QD
126051981 12605198 9 C POTASSIUM PILL KLO 2 Oral 0 10 MEQ QD
126051981 12605198 10 C WATER PILL GENERIC FOR FUROSEMIDE 2 Oral 0 20 MG QD
126051981 12605198 11 C MELOXICAM. MELOXICAM 1 0 15 MG QD
126051981 12605198 12 C MELOXICAM. MELOXICAM 1 0 15 MG QD
126051981 12605198 13 C GABAPENTIN. GABAPENTIN 1 0 300 MG BID
126051981 12605198 14 C GABAPENTIN. GABAPENTIN 1 0 300 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126051981 12605198 1 Gastrooesophageal reflux disease
126051981 12605198 2 Gastrooesophageal reflux disease
126051981 12605198 3 Gastrooesophageal reflux disease
126051981 12605198 4 Gastrooesophageal reflux disease
126051981 12605198 5 Gastrooesophageal reflux disease
126051981 12605198 6 Gastrooesophageal reflux disease
126051981 12605198 7 Atrial fibrillation
126051981 12605198 10 Fluid retention
126051981 12605198 11 Pain in extremity
126051981 12605198 12 Neuropathy peripheral
126051981 12605198 13 Pain in extremity
126051981 12605198 14 Neuropathy peripheral

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126051981 12605198 Blood glucose decreased
126051981 12605198 Chest pain
126051981 12605198 Circumstance or information capable of leading to medication error
126051981 12605198 Diabetes mellitus
126051981 12605198 Drug ineffective
126051981 12605198 Dyspepsia
126051981 12605198 Intentional product misuse

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126051981 12605198 1 2003 0
126051981 12605198 2 2003 0
126051981 12605198 3 2015 2015 0
126051981 12605198 4 2015 2015 0
126051981 12605198 5 2015 2015 0
126051981 12605198 6 2015 2015 0
126051981 12605198 7 2014 0
126051981 12605198 8 2013 0
126051981 12605198 9 2014 0
126051981 12605198 10 2014 0
126051981 12605198 11 201606 0
126051981 12605198 12 201606 0